{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T17:23:03Z","timestamp":1782580983708,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T00:00:00Z","timestamp":1597622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00415-020-10153-6","type":"journal-article","created":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T09:06:41Z","timestamp":1597655201000},"page":"321-336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Tics induced by antiepileptic drugs: a pragmatic review"],"prefix":"10.1007","volume":"268","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7533-4388","authenticated-orcid":false,"given":"James","family":"Peters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirosen","family":"Vijiaratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Angus-Leppan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,17]]},"reference":[{"key":"10153_CR1","first-page":"267","volume":"15","author":"J Jankovic","year":"1997","unstructured":"Jankovic J (1997) Phenomenology and classification of tics. Tourette Syndrome 15:267\u2013275","journal-title":"Tourette Syndrome"},{"key":"10153_CR2","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1002\/mds.23618","volume":"26","author":"J Jankovic","year":"2011","unstructured":"Jankovic J, Kurlan R (2011) Tourette syndrome: evolving concepts. Mov Disord 26:1149\u20131156","journal-title":"Mov Disord"},{"key":"10153_CR3","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1212\/WNL.57.8.1383","volume":"57","author":"R Kurlan","year":"2001","unstructured":"Kurlan R, McDermott MP, Deeley C et al (2001) Prevalence of tics in school children and association with placement in special eduction. Neurology 57:1383\u20131388","journal-title":"Neurology"},{"key":"10153_CR4","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders, 5th edn. Arlington, American Psychiatric Association","edition":"5"},{"key":"10153_CR5","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1212\/WNL.0b013e3181a187dd","volume":"72","author":"RL Albin","year":"2009","unstructured":"Albin RL, Koepe RA, Wernette K et al (2009) Striatal [11C] dihydrotetrabenazine and [11C] methylphenidate binding in Tourette syndrome. Neurology 72:1390\u20131396","journal-title":"Neurology"},{"key":"10153_CR6","doi-asserted-by":"publisher","first-page":"13307","DOI":"10.1073\/pnas.0502624102","volume":"102","author":"PS Kalanithi","year":"2005","unstructured":"Kalanithi PS, Zheng W, Kataoka Y et al (2005) Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome. Proc Natl Acad Sci U S A 102:13307\u201313312","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10153_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/cne.22206","volume":"518","author":"Y Kataoka","year":"2010","unstructured":"Kataoka Y, Kalanithi PS, Grantz H et al (2010) Decreased number of parvalbumin and cholinergic interneurons in the striatum of individuals with Tourette syndrome. J Comp Neurol 518:277\u2013291","journal-title":"J Comp Neurol"},{"key":"10153_CR8","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1093\/brain\/aws104","volume":"135","author":"A Lerner","year":"2012","unstructured":"Lerner A, Bagic A, Simmons JM et al (2012) Widespread abnormality of the y-aminobutyric acid-ergic system in Tourette syndrome. Brain 135:1926\u20131936","journal-title":"Brain"},{"key":"10153_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ncl.2014.09.008","volume":"33","author":"C Ganos","year":"2015","unstructured":"Ganos C, Martino D (2015) Tics and tourette syndrome. Neurol Clin 33:115\u2013136","journal-title":"Neurol Clin"},{"key":"10153_CR10","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1212\/01.wnl.0000264417.18604.12","volume":"68","author":"A Lerner","year":"2007","unstructured":"Lerner A, Bagic A, Boudreau EA et al (2007) Neuoimaging of neuronal circuits involved in tic generation in patients with Tourette syndrome. Neurology 68:1979\u20131987","journal-title":"Neurology"},{"key":"10153_CR11","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1212\/WNL.0b013e3182104106","volume":"76","author":"M Pourfar","year":"2011","unstructured":"Pourfar M, Feignin A, Tang CC et al (2011) Abnormal metabolic brain networks in Tourette syndrome. Neurology 76:944\u2013952","journal-title":"Neurology"},{"key":"10153_CR12","first-page":"61","volume":"99","author":"J Jankovic","year":"2006","unstructured":"Jankovic J, Mejia NI (2006) Tics associated with other disorders. Adv Neurol 99:61\u201368","journal-title":"Adv Neurol"},{"key":"10153_CR13","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1528-1157.1986.tb03549.x","volume":"27","author":"Collaborative Group for epidemiology of epilepsy","year":"1986","unstructured":"Collaborative Group for epidemiology of epilepsy (1986) Adverse reactions to antiepileptic drugs: a multicentre survey of clinical practice. Epilepsia 27:323\u2013330","journal-title":"Epilepsia"},{"key":"10153_CR14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1684\/j.1950-6945.2004.tb00064.x","volume":"6","author":"G Zaccara","year":"2004","unstructured":"Zaccara G, Cincotta M, Borgheresi A, Balestrieri F (2004) Adverse motor effects induced by antiepileptic drugs. Epileptic Disord 6:153\u2013168","journal-title":"Epileptic Disord"},{"key":"10153_CR15","first-page":"52","volume":"6","author":"C Lombroso","year":"1999","unstructured":"Lombroso C (1999) Lamotrigine-induced tourettism. Neurology 6:52","journal-title":"Neurology"},{"key":"10153_CR16","doi-asserted-by":"crossref","unstructured":"Sotero de Menezes MA, Rho JM, Murphy P, Cheyette S (2000) Lamotrigine-induced tic disorder: report of five pediatric cases. Epilepsia 7:862\u2013867.","DOI":"10.1111\/j.1528-1157.2000.tb00254.x"},{"key":"10153_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1176\/appi.ajp.163.1.159","volume":"163","author":"F Seemuller","year":"2006","unstructured":"Seemuller F, Dehning S, Grunze H, Muller N (2006) Tourette\u2019s symptoms provoked by lamotrigine in a bipolar patient. Am J Psychiatry 163:159","journal-title":"Am J Psychiatry"},{"key":"10153_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3988\/jcn.2007.3.2.93","volume":"3","author":"DG Kim","year":"2007","unstructured":"Kim DG, Oh SH, Kim OJ (2007) A case of lamotrigine-induced excessive involuntary eye blinking. J Clin Neurol 3:93\u201395","journal-title":"J Clin Neurol"},{"key":"10153_CR19","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.pnpbp.2007.04.015","volume":"31","author":"T Alkin","year":"2007","unstructured":"Alkin T, Onur E, Ozerdem A (2007) Co-occurrence of blepharospasm, tourettism and obsessive-compulsive symptoms during lamotrigine treatment. Prog Neuropsychopharmacol Biol Psychiatry 31:1339\u20131340","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10153_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.pediatrneurol.2012.04.026","volume":"47","author":"S Thome-Souza","year":"2012","unstructured":"Thome-Souza S, Moreira B, Valente KD (2012) Late adverse effects of the coadministration of valproate and lamotrigine. Pediatr Neurol 47:47\u201350","journal-title":"Pediatr Neurol"},{"key":"10153_CR21","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1002\/mds.23120","volume":"25","author":"ES Musiek","year":"2010","unstructured":"Musiek ES, Anderson CT, Dahodwala NA, Pollard JR (2010) Facial tic associated with lamotrigine in adults. Mov Disord 25:1512\u20131513","journal-title":"Mov Disord"},{"key":"10153_CR22","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1089\/cap.2013.0057","volume":"23","author":"D Lu","year":"2013","unstructured":"Lu D, Lin X, Liu X, Su L (2013) Lamotrigine-induced facial tic in a pediatric bipolar disorder patient. J Child Adolesc Psychopharmacol 23:583\u2013583","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10153_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2174\/1574886311207040269","volume":"11","author":"MB Centorino","year":"2016","unstructured":"Centorino MB, Catalano G, Catalano M (2016) Lamotrigine induced whole body tics: a case report and literature review. Curr Drug Saf 11:189\u2013191","journal-title":"Curr Drug Saf"},{"key":"10153_CR24","doi-asserted-by":"crossref","unstructured":"Angus-Leppan H, Nash A, Pilling R (2019) Recognising acute lamotrigine induced Tourette\u2019s syndrome in adults. Sci J Res Rev1: open access.","DOI":"10.33552\/SJRR.2019.01.000515"},{"key":"10153_CR25","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1542\/peds.73.6.841","volume":"73","author":"JP Neglia","year":"1984","unstructured":"Neglia JP, Glaze DG, Zion TE (1984) Tics and vocalizations in children treated with carbamazepine. Pediatrics 73:841\u2013843","journal-title":"Pediatrics"},{"key":"10153_CR26","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1469-8749.1984.tb04487.x","volume":"26","author":"CT Gualtieri","year":"1984","unstructured":"Gualtieri CT, Evans RW (1984) Carbamazepine-induced tics. Dev Med Child Neurol 26:546\u2013548","journal-title":"Dev Med Child Neurol"},{"key":"10153_CR27","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1528-1157.1987.tb03680.x","volume":"28","author":"U Aguglia","year":"1987","unstructured":"Aguglia U, Zappia M, Quattrone A (1987) Carbamazepine-induced nonepileptic myoclonus in a child with benign epilepsy. Epilepsia 28:515\u2013518","journal-title":"Epilepsia"},{"key":"10153_CR28","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/00002826-198908000-00007","volume":"12","author":"R Kurlan","year":"1989","unstructured":"Kurlan R, Kersun J, Behr J et al (1989) Carbamazepine-induced tics. Clin Neuropharmacol 12:298\u2013302","journal-title":"Clin Neuropharmacol"},{"key":"10153_CR29","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/j.1528-1157.1993.tb02119.x","volume":"34","author":"PL Robertson","year":"1993","unstructured":"Robertson PL, Garofalo EA, Silverstein FS, Komarynski MA (1993) Carbamazepine-induced tics. Epilepsia 34:965\u2013968","journal-title":"Epilepsia"},{"key":"10153_CR30","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/j.1532-5415.1995.tb05568.x","volume":"43","author":"PN Tariot","year":"1995","unstructured":"Tariot PN, Frederiksen K, Erb R et al (1995) Lack of carbamazepine toxicity in frail nursing home patients: a controlled study. J Am Geriatr Soc 43:1026\u20131029","journal-title":"J Am Geriatr Soc"},{"key":"10153_CR31","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1684\/j.1950-6945.2000.tb00348.x","volume":"2","author":"M Holtmann","year":"2000","unstructured":"Holtmann M, Korn-Merker E, Boenigk HE (2000) Carbamazepine-induced combined phonic and motor tic in a boy with Down Syndrome. Epileptic Disord 2:39\u201340","journal-title":"Epileptic Disord"},{"key":"10153_CR32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1684\/epd.2012.0504","volume":"14","author":"A Magaudda","year":"2012","unstructured":"Magaudda A, Di Rosa G (2012) Carbamazepine-induced non-epileptic myoclonus and tic-like movements. Epileptic Disord 14:172\u2013173","journal-title":"Epileptic Disord"},{"key":"10153_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/0887-8994(86)90042-1","volume":"2","author":"R Sandyk","year":"1985","unstructured":"Sandyk R (1985) Phenobarbital-induced Tourette-like Symptoms. Pediatr Neurol 2:54\u201355","journal-title":"Pediatr Neurol"},{"key":"10153_CR34","first-page":"419","volume":"31","author":"L Burd","year":"1986","unstructured":"Burd L, Kerbeshian J, Fisher W, Gascon G (1986) Anticonvulsant medications: an iatrogenic cause of tics disorders can. J Psychiatry 31:419\u2013423","journal-title":"J Psychiatry"},{"key":"10153_CR35","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/pgmj.63.738.311-a","volume":"63","author":"MA Gillman","year":"1987","unstructured":"Gillman MA, Sandyk R (1987) Clonazepam-induced Tourette syndrome in a subject with hyperexplexia. Postgrad Med J 63:311\u2013312","journal-title":"Postgrad Med J"},{"key":"10153_CR36","doi-asserted-by":"crossref","unstructured":"Montazerlotfelahi H, Amanat M, Tavasoli A et al (2019) Levetiracetam for prophylactic treatment of pediatric migraine: a randomized double-blind placebo-controlled trial. Cephalalgia; Epub.","DOI":"10.1177\/0333102419851814"},{"key":"10153_CR37","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1177\/000992288502400604","volume":"24","author":"ME Drake","year":"1985","unstructured":"Drake ME, Cannon PA (1985) Tourette\u2019s syndrome precipitated by phenytoin. Clin Pediatr 24:323","journal-title":"Clin Pediatr"},{"key":"10153_CR38","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.pediatrneurol.2010.12.003","volume":"44","author":"L Guilhoto","year":"2011","unstructured":"Guilhoto L, Loddenkemper T, Gooty V et al (2011) Experience with lacosamide in a series of children with drug-resistant focal epilepsy. Pediatr Neurol 44:414\u2013419","journal-title":"Pediatr Neurol"},{"key":"10153_CR39","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/B978-0-12-411546-0.00016-0","volume":"112","author":"M Madruga-Garrido","year":"2013","unstructured":"Madruga-Garrido M, Mir P (2013) Tics and other stereotyped movements as side effects of pharmacological treatment. Int Rev Neurobiol 112:481\u2013493","journal-title":"Int Rev Neurobiol"},{"key":"10153_CR40","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.seizure.2007.12.003","volume":"17","author":"G Zaccara","year":"2008","unstructured":"Zaccara G, Gangemi P, Cincotta M (2008) Central nervous system adverse effects of new antiepileptic drugs: a meta-analysis of placebo-controlled studies. Seizure 17:405\u2013421","journal-title":"Seizure"},{"key":"10153_CR41","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1002\/mds.23199","volume":"25","author":"J Jankovic","year":"2010","unstructured":"Jankovic J, Gelineau-Kattner R, Davidson A (2010) Tourette syndrome in adults. Mov Disord 25:2171\u20132175","journal-title":"Mov Disord"},{"key":"10153_CR42","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0920-1211(97)00042-9","volume":"28","author":"M Okada","year":"1997","unstructured":"Okada M, Hirano T, Mizuno K et al (1997) Biphasic effects of carbamazepine on the dopaminergic system in the rat striatum and hippocampus. Epilepsy Res 28:143\u2013153","journal-title":"Epilepsy Res"},{"key":"10153_CR43","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2147\/NDT.S6371","volume":"6","author":"MA Martinez-Granero","year":"2010","unstructured":"Martinez-Granero MA, Garia-Perez A, Montanes F (2010) Levetiracetam as an alternative therapy for Tourette syndrome. Neuropsychiatr Dis Treat 6:309\u2013316","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10153_CR44","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1212\/WNL.0000000000007467","volume":"92","author":"T Pringsheim","year":"2019","unstructured":"Pringsheim T, Holler-Mangan Y, Okun M et al (2019) Comprehensive systematic review summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 92:907\u2013915","journal-title":"Neurology"},{"key":"10153_CR45","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ridd.2015.10.019","volume":"51","author":"WC Weng","year":"2016","unstructured":"Weng WC, Huang HL, Wong LC et al (2016) Increased risks of tic disorders in children with epilepsy: a nation-wide population-based case-control study in Taiwan. Res Dev Disabil 51:173\u2013180","journal-title":"Res Dev Disabil"},{"key":"10153_CR46","first-page":"373","volume":"112","author":"Y Bozzi","year":"2013","unstructured":"Bozzi Y, Borrelli E (2013) The role of dopamine signalling in epileptogenesis. Front Cell Neurosci 112:373\u2013389","journal-title":"Front Cell Neurosci"},{"key":"10153_CR47","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1124\/pr.115.012021","volume":"68","author":"M Brodie","year":"2016","unstructured":"Brodie M, Besag F, Ettinger A et al (2016) Epilepsy, antiepileptic drugs, and aggression: an evidence-base review. Pharmacol Rev 68:563\u2013602","journal-title":"Pharmacol Rev"},{"key":"10153_CR48","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1126\/science.1116502","volume":"310","author":"JF Abelson","year":"2005","unstructured":"Abelson JF, Kwan KY, O\u2019Roak BJ et al (2005) Sequence variants in SLITRK1 are associated with Tourette\u2019s syndrome. Science 310:317\u2013320","journal-title":"Science"},{"key":"10153_CR49","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1056\/NEJMoa0907006","volume":"362","author":"AG Ercan-Sencicek","year":"2010","unstructured":"Ercan-Sencicek AG, Stilman AA, Ghosh AK et al (2010) L-Histidine decarboxylase and Tourette\u2019s syndrome. NEJM 362:1901\u20131908","journal-title":"NEJM"},{"key":"10153_CR50","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1016\/j.celrep.2018.12.024","volume":"24","author":"S Wang","year":"2018","unstructured":"Wang S, Mandell JD, Kumar Y et al (2018) De novo sequence and copy number variants are strongly associated with Tourette disorder and implicate cell polarity in pathogenesis. Cell Rep 24:3544","journal-title":"Cell Rep"},{"key":"10153_CR51","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/JCP.0b013e31823f8770","volume":"32","author":"S Comai","year":"2012","unstructured":"Comai S, Tau M, Gobbi G (2012) The psychopharmacology of aggressive behaviour: a translational approach: part 1: neurobiology. J Clin Psychopharmacol 32:83\u201394","journal-title":"J Clin Psychopharmacol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10153-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-10153-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10153-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T22:41:24Z","timestamp":1723416084000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-10153-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,17]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10153"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-10153-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,17]]},"assertion":[{"value":"28 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Nirosen Vijiaratnam: educational support from Abbvie, Stada, Ipsen and Merc, speaker\u2019s honorarium from Abbvie and Stada and advisory boards for Abbvie. Heather Angus-leppan: non-pharmaceutical grants (2017) and honoraria for non-promotional lectures\u2014Eisai (2017, 2019) and UCB (2016),Valproate MHRA stakeholders meeting representative (2018) and UK representative on the Sanofi European Valproate educational programme Advisory Board. The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}